C1704417 - Type IIb hyperlipoproteinemia is caused by mutation in the receptor-binding domain of APOLIPOPROTEIN B-100 which is a major component of LOW-DENSITY LIPOPROTEINS and VERY-LOW-DENSITY LIPOPROTEINS resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and HYPERTRIGLYCERIDEMIA (combined hyperlipidemia).

home UMLS 2020

293,031 терминов и синонимов из MeSH и LOINC

Поиск по CUI	Поиск по CODE
Поиск по одному или нескольким словам или частям слов

Lang Dictionary CODE			LUI	preferred no	SUI	preference Yes / No	Terms, descriptions
							CUI C1704417

Russian	MDRRUS	10045264	L16082284	preferred	S19403157	Y	Гиперлипопротеинемия IIb типа
Russian	MDRRUS	10017345	L16061260	no	S19403161	Y	Гиперлипопротеинемия Фредриксона IIb типа
Russian	MDRRUS	10054676	L16113793	no	S19403166	Y	Гиперлипопротеинемия типа IIb
Russian	MDRRUS	10060598	L16124306	no	S19403165	Y	Гиперлипопротеинемия типа IIb по Фредриксону
	Medical Subject Headings				A26620040	AT64676349	Type IIb hyperlipoproteinemia is caused by mutation in the receptor-binding domain of APOLIPOPROTEIN B-100 which is a major component of LOW-DENSITY LIPOPROTEINS and VERY-LOW-DENSITY LIPOPROTEINS resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and HYPERTRIGLYCERIDEMIA (combined hyperlipidemia).